Matthieu Chodorge

Person

Cambridge, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 11,518,809
- Issue date Dec 6, 2022
- MedImmune Limited
- Christophe Queva
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for LOX1 and use in treatment of cardiovascular...
- Patent number 11,078,284
- Issue date Aug 3, 2021
- MedImmune Limited
- Andrew Buchanan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 10,400,039
- Issue date Sep 3, 2019
- MedImmune Limited
- Christophe Queva
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for LOX1 and use in treatment of cardiovascular...
- Patent number 10,117,889
- Issue date Nov 6, 2018
- MedImmune Limited
- Andrew Buchanan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PCSK9-GLP-1 fusions and methods for use
- Patent number 10,077,319
- Issue date Sep 18, 2018
- MedImmune, LLC
- Anthony Celeste
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 9,493,565
- Issue date Nov 15, 2016
- MedImmune Limited
- Christophe Queva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 8,779,108
- Issue date Jul 15, 2014
- MedImmune, Limited
- Christophe Queva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES SPECIFIC FOR LOX1 AND USE IN TREATMENT OF CARDIOVASCULAR...
- Publication number 20210347900
- Publication date Nov 11, 2021
- MEDIMMUNE LIMITED
- Andrew BUCHANAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20210017282
- Publication date Jan 21, 2021
- MEDIMMUNE LIMITED
- CHRISTOPHE QUEVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF
- Publication number 20190262368
- Publication date Aug 29, 2019
- MEDIMMUNE LIMITED
- Andrew BUCHANAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE
- Publication number 20190092877
- Publication date Mar 28, 2019
- Medimmune, LLC
- Anthony Celeste
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF
- Publication number 20170304343
- Publication date Oct 26, 2017
- MEDIMMUNE LIMITED
- Andrew BUCHANAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20170137522
- Publication date May 18, 2017
- MEDIMMUNE LIMITED
- CHRISTOPHE QUEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE
- Publication number 20160369010
- Publication date Dec 22, 2016
- Medimmune, LLC
- Anthony Celeste
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20140356353
- Publication date Dec 4, 2014
- CHRISTOPHE QUEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Targeted Binding Agents Against B7-H1
- Publication number 20130034559
- Publication date Feb 7, 2013
- Medlmmune Limited
- Christophe Queva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Matthieu Chodorge

Person

Patents Grantslast 30 patents

Targeted binding agents against B7-H1

Antibodies specific for LOX1 and use in treatment of cardiovascular...

Targeted binding agents against B7-H1

Antibodies specific for LOX1 and use in treatment of cardiovascular...

Anti-PCSK9-GLP-1 fusions and methods for use

Targeted binding agents against B7-H1

Targeted binding agents against B7-H1

Patents Applicationslast 30 patents

ANTIBODIES SPECIFIC FOR LOX1 AND USE IN TREATMENT OF CARDIOVASCULAR...

TARGETED BINDING AGENTS AGAINST B7-H1

BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF

ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE

BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF

TARGETED BINDING AGENTS AGAINST B7-H1

ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE

TARGETED BINDING AGENTS AGAINST B7-H1

Targeted Binding Agents Against B7-H1